Management in robot-assisted radical prostatectomy patients with recto-urethral fistulas: the York–Mason technique - Takeaways - MDSpire

Management in robot-assisted radical prostatectomy patients with recto-urethral fistulas: the York–Mason technique

  • By

  • Sophia H. van der Graaf

  • Esther M. K. Wit

  • Geerard L. Beets

  • Brechtje A. Grotenhuis

  • Ton A. Roeleveld

  • Jakko A. Nieuwenhuijzen

  • André N. Vis

  • Pim J. van Leeuwen

  • Henk G. van der Poel

  • October 11, 2025

  • 0 min

Share

  • 1

    Robot-assisted radical prostatectomy (RARP) is a common treatment for localized prostate cancer but carries risks, including recto-urethral fistula (RUF).

  • 2

    The incidence of RUF after primary RARP is low, at up to 0.53%, but can rise to 16% after salvage prostatectomy, significantly impacting quality of life.

  • 3

    Treatment for RUF varies; conservative management is preferred initially, while surgical intervention is necessary if symptoms persist after three months.

  • 4

    The York–Mason technique is a posterior transsphincteric surgical approach that allows precise closure of RUFs, providing direct access through healthy tissue.

  • 5

    A retrospective study at the AVL-NCI analyzed outcomes of the York–Mason technique for RUF in RARP patients, emphasizing the need for individualized treatment.

Original Source(s)

Management in robot-assisted radical prostatectomy patients with recto-urethral fistulas: the York–Mason technique

  • by Sophia H. van der Graaf, Esther M. K. Wit, Geerard L. Beets, Brechtje A. Grotenhuis, Ton A. Roeleveld, Jakko A. Nieuwenhuijzen, André N. Vis, Pim J. van Leeuwen, Henk G. van der Poel

  • October 11, 2025

Related Content

Safety and efficacy of concomitant holmium laser enucleation of the prostate with transurethral endoscopic management of symptomatic large bladder diverticulum: revisiting a historical technique in the modern era with literature review

Association of energy source with outcomes in en bloc TURB: secondary analysis of a randomized trial

Transurethral resection of the prostate in the extreme elderly (≥ 85 years): treatment success, morbidity and survival